PTH and breast carcinoma: Breast cancer cells that metastasize to bone secrete parathyroid hormone-related peptide (PTHrP), which activates PTH/PTHrP receptors (PTHR1) on osteoblasts, leading to the release of receptor activator of nuclear factor-kappaB (RANK) ligand [2,3,4].